BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

GE HealthCare Launches Vibe CT System to Expand Access to Advanced Cardiac Imaging

GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that hel...

March 31, 2025 | News

Siemens Healthineers’ Innovance Antithrombin Assay Cleared by FDA as Companion Diagnostic for Sanofi’s Qfitlia

The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring AT activity levels helps people receive the approp...

March 31, 2025 | News

ZEISS and DORC Secure NMPA Approval in China for ILM-Blue®, Advancing Retinal Surgery Standards

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V...

March 28, 2025 | News

Gene Solutions Achieves Landmark Validation for Asia’s First Clinically Proven Multi-Cancer Blood Test, SPOT-MAS

Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. Common cance...

March 27, 2025 | News

Shanghai ArkBio Completes Phase III Trial of AK0901 for Pediatric ADHD in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of a...

March 25, 2025 | News

GSK’s Omjjara Receives Local Approval in Singapore for Myelofibrosis Patients with Moderate to Severe Anaemia

Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib Nearly all myelof...

March 25, 2025 | News

Shanghai Moyom’s Aphranel® MagiCCrystal Becomes First NMPA-Approved CaHA Filler in China

Shanghai Moyom Biotechnology's high-profile brand, Aphranel® MagiCCrystal CaHA Filler, has officially obtained Class III Medical Device ...

March 24, 2025 | Regulatory

Menarini Group, Stemline, and VisualDx Join Forces to Boost Early Detection of BPDCN Using AI-Driven Skin Imaging

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 ...

March 21, 2025 | News

TPIsoftware & Yuan's General Hospital Transform Healthcare with GenAI Platform

TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digit...

March 20, 2025 | News

Vatech and Pearl Partner to Elevate Dental AI Diagnostics with Seamless Integration

Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at tra...

March 19, 2025 | News

Lunit Secures Multi-Year AI Partnership with SEHA to Advance Breast Cancer Screening in UAE

Lunit , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has signed a multi-year contract with Abu Dha...

March 19, 2025 | News

Akeso’s Penpulimab Secures NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National ...

March 18, 2025 | News

VISTA Eye Specialist Advances Cataract Surgery in Malaysia with AI and Leading Ophthalmic Technologies

Klinik Pakar Mata VISTA Eye Specialist (VISTA), a well-established name in eye care in Malaysia, continues to improve its cataract surg...

March 17, 2025 | News

Teva Hong Kong Partners with Kerry Pharma to Enhance Medicine Distribution Across Hong Kong, Macau, and the Greater Bay Area

Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Ke...

March 17, 2025 | News

Stay Connected